A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...
Author(s)Goldschmidt H, Moreau P, Ludwig H, et al. Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ...
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma ...
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for ...
A British trial showing that a common steroid could reduce deaths in severe COVID-19 cases by one-third was good news for Minnesota physicians who have been battling the infectious disease without a ...
A potential COVID-19 treatment is delivering promising results in clinical trials, with dexamethasone helping cut deaths in cases of severe respiratory complications. The potential of the drug, a ...
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results